ARWR
#973
Arrowhead Pharmaceuticals, Inc. - Common Stock
60.7 6 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.17%
Changement Mensuel
-26.54%
Evolution sur 6 mois
-6.67%
Changement Annuel
+55.40%
Clôture Précédente
62.7 5
Open
62.4 9
Low
60.4 8
High
62.4 9
Financials
- Market Capitalization 8.58 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3 449
ratio cours/chiffre d'affaires
5.56
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 962 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.79 USD | -0.19% | -0.05% | -14.58% | +8.07% | 8.73 B USD | ||
| 963 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 165.87 USD | -1.47% | -6.33% | -25.26% | +27.40% | 8.69 B USD | ||
| 982 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.28 USD | -0.16% | +2.41% | +2.43% | +64.18% | 8.46 B USD | ||
| 1043 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 85.91 USD | +0.26% | -7.42% | -5.18% | +259.31% | 7.58 B USD |